EIGER BIOPHARMACEUTICALS INC (EIGR) Stock Cash Flow
NASDAQ:EIGR - Nasdaq - US28249U2042 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -74.96M | -96.78M | -33.92M | -65.05M | -70.25M | |||
| Depreciation Amortization | 275.00K | 290.00K | 280.00K | 170.00K | 70.00K | |||
| Change In Working Capital | -5.73M | 480.00K | -1.62M | -5.90M | -10.00K | |||
| Interest Paid | 3.97M | 2.89M | 2.78M | 2.79M | 2.64M | |||
| Taxes Paid | 269.00K | 60.00K | N/A | N/A | N/A | |||
| Other non cash items | 5.87M | 12.99M | -36.08M | 7.60M | 6.58M | |||
| OPERATING CASH FLOW | -74.55M | -83.01M | -71.34M | -63.19M | -63.61M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -234.00K | -340.00K | -230.00K | -260.00K | -480.00K | |||
| Other Investing Activity | 74.46M | 9.97M | 61.76M | -44.53M | -16.00M | |||
| INVESTING CASH FLOW | 74.23M | 9.63M | 61.53M | -44.79M | -16.47M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 5.45M | -180.00K | 0.00 | 4.96M | |||
| Stock Issued/Repurchased | 56.00K | 71.79M | 3.66M | 97.49M | 54.17M | |||
| Other Financing Activity | -15.00K | -290.00K | -320.00K | -20.00K | -930.00K | |||
| FINANCING CASH FLOW | 41.00K | 76.96M | 3.17M | 97.46M | 58.20M | |||
| Exchange Rate Effect | -79.00K | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -358.00K | 3.58M | -6.64M | -10.52M | -21.88M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -74.55M | -83.01M | -71.34M | -63.19M | -63.61M | |||
| Capital Expenditure | -234.00K | -340.00K | -230.00K | -260.00K | -480.00K | |||
| FREE CASH FLOW | -74.78M | -83.35M | -71.57M | -63.45M | -64.09M | |||
All data in USD